Security key
G5890A102
Keenova Therapeutics plc - Common Stock, par value $0.01 per share (MNKTQ)
CUSIP: G5890A102
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 10,483,926
- Total 13F value
- $12,366,901
- Share change
- +170,125
- SEC-reported price per share
- $1.18
- Number of holders
- 35
- Value change
- -$11,282,467
- Number of buys
- 15
- Number of sells
- 25
- Shares outstanding
- 39,705,355
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
35
Top holders
10
MNKTQ full security history
Ownership snapshot
Full 13F holder table
Keenova Therapeutics plc SEC filings
Keenova Therapeutics plc company facts
Broader feeds
Ownership snapshot
Top reported holders of MNKTQ - Keenova Therapeutics plc - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bracebridge Capital, LLC
Disclosed value leader
Alta Fundamental Advisers...
Comparable rows
15/15
Latest evidence
16 Jun 2023
13F
3/4/5
Lead comparable stake: 5.1%
Showing 1-6 of 15 holder rows.
Quick read
Bracebridge Capital, LLC leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bracebridge Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Bracebridge Capital, LLC
5.1%
JPMORGAN CHASE & CO
4.2%
Hudson Bay Capital Management LP
2.9%
Alta Fundamental Advisers LLC
1.8%
FEDERATED HERMES, INC.
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bracebridge Capital, LLC |
13F
Company
|
5.1%
|
$14,822,647
2,033,257 shares
|
— | 31 Mar 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
4.2%
|
$12,259,000
1,681,638 shares
|
— | 31 Mar 2023 |
| Hudson Bay Capital Management LP |
13F
Company
|
2.9%
|
$8,322,087
1,141,560 shares
|
— | 31 Mar 2023 |
| Alta Fundamental Advisers LLC |
3/4/5
13F
10%+ Owner · Company
|
1.8%
from 13F
|
$73,015,988
1,947,093 shares
|
— | 16 Jun 2023 |
| FEDERATED HERMES, INC. |
13F
Company
|
1.8%
|
$5,164,265
708,404 shares
|
— | 31 Mar 2023 |
| Sculptor Capital LP |
13F
Company
|
1.7%
|
$5,064,061
694,649 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
10,483,926
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
44
Q2 2023 holders
35
Holder diff
-9
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|